Pulmonary delivery of nucleic acids

Area of Science:

• Pulmonary Medicine
• Gene Therapy
• Drug Delivery Systems

Background:

• The lung is a promising target for gene therapy to treat genetic disorders, cancer, and infections.
• Despite decades of research, clinical gene therapy applications face significant hurdles.
• Pulmonary gene therapy requires efficient delivery of nucleic acid cargo to specific lung cells.

Discussion:

• Pulmonary architecture, clearance mechanisms, and immune responses impede effective gene delivery.
• Conventional nebulizers and inhalers may not be optimal for delivering DNA to the lung.
• Developing specialized formulation and device solutions is crucial for successful nucleic acid delivery.

Key Insights:

• Gene therapy offers potential for diverse lung conditions, from inherited diseases to infections.
• Significant challenges exist in achieving targeted and effective gene delivery within the complex lung environment.
• Overcoming biological and physical barriers is essential for realizing the clinical potential of pulmonary gene therapy.

Outlook:

• Future research should focus on integrated formulation and device strategies for pulmonary gene therapy.
• Developing representative biological models is critical for testing and optimizing gene delivery systems.
• Advancements in drug delivery are key to unlocking the therapeutic promise of gene therapy in the lung.